multivirus-specific T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for multivirus-specific T cells, covering 2023-10-10 to 2023-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT [Phase 1, Phase 2]